首页> 外文期刊>International journal of antimicrobial agents >Antimicrobial resistance of Salmonella enterica group C strains isolated from humans in Turkey, 2000-2002
【24h】

Antimicrobial resistance of Salmonella enterica group C strains isolated from humans in Turkey, 2000-2002

机译:2000-2002年在土耳其从人中分离出的肠炎沙门氏菌C组菌株的抗药性

获取原文
获取原文并翻译 | 示例
       

摘要

Fifty-three Salmonella enterica group C isolates obtained from various human samples (47 stool, 4 blood and 2 urine) in ten provinces of Turkey between 1 July 2000 and 30 June 2002 were serotyped and resistance to antimicrobials was investigated by agar dilution tests. The isolates were identified as S. Choleraesuis (11), S. Hadar (7), S. Irumu (4), S. Virchow (3), S. Tallahassee (3), S. Paratyphi C (2), S. Braenderup (2), S. Othmarschen (2), S. Menston (2), S. Concord (2), S. Infantis (2), S. Kottbus (2), S. Edinburg (1), S. Oramenburg (1), S. Muenchen (1) and S. Malmoe (1). Antimicrobial resistance rates of S. enterica groups C-1 and C-2 were high for ampicillin (26% and 60%, respectively), amoxicillin/clavulanic acid (11% and 40%), chloramphenicol (16% and 27%) and tetracycline (3% and 40%). The percentages of strains sensitive to all antimicrobials were 58% and 33%, respectively. Multiresistance was not observed in group C, isolates, but the rate of multiresistant isolates was 13% in group C-2. The rate of decreased ciprofloxacin susceptibility (Ci(PL)) was 61% in serogroup C-1 and 20% in serogroup C-2. These results indicated that S. enterica group C infections in humans were not infrequent in Turkey and that multiple antimicrobial resistance was common within these strains. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
机译:对2000年7月1日至2002年6月30日期间从土耳其十个省份的各种人类样品(47个粪便,4个血液和2个尿液)中获得的53株C型沙门氏菌进行了血清分型,并通过琼脂稀释试验研究了其对抗菌剂的耐药性。分离物被鉴定为霍乱链球菌(S.Choleraesuis)(11),哈达尔链球菌(S.Hadar)(7),伊鲁木链球菌(S.Irumu)(4),链球菌S.Virchow(3),塔拉哈西链球菌(S.Tallahassee)(3),副伤寒沙门氏菌(S.Paratyphi C)(2),S。 Braenderup(2),S。Othmarschen(2),S。Menston(2),S。Concord(2),S。Infantis(2),S。Kottbus(2),S。Edinburg(1),S。Oramenburg (1),S。Muenchen(1)和S. Malmoe(1)。肠炎链球菌C-1和C-2组对氨苄西林(分别为26%和60%),阿莫西林/克拉维酸(11%和40%),氯霉素(16%和27%)和抗生素的耐药率较高四环素(3%和40%)。对所有抗菌药物敏感的菌株的百分比分别为58%和33%。在C组分离株中未观察到多耐药性,但在C-2组中多耐药株的发生率为13%。环丙沙星敏感性降低率(Ci(PL))在血清群C-1中为61%,在血清群C-2中为20%。这些结果表明,在土耳其人肠炎链球菌C组感染并不罕见,并且在这些菌株中常见多种抗药性。 (c)2005年Elsevier B.V.和国际化学疗法学会。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号